The Radiochemistry, Preclinical Efficacy & Immunogenicity Of 212Pb- Based Radiopharmaceuticals

Time: 2:00 pm
day: Day Two

Details:

  • Develop radiochemistry for rapid reaction with Pb-212 and stable chelation of progeny Bi-212 daughters
  • Pb-203 surrogate predicts in vivo biodistribution of Pb-212 and progeny Bi-212
  • The immunogenicity of alpha-radiotherapy and synergy with immunotherapy in
    melanoma

Speakers: